文献速递消化内镜胰腺与胆道疾病

EUS引导经肠ERCP在非Roux-en-Y胃旁路手术解剖患者中的应用

EUS-directed transenteric ERCP in non-Roux-en-Y gastric bypass surgical anatomy patients (with video).
PubMed 文献 · Gastrointest Endosc · 2020-01-07

多中心回顾性研究纳入18例非Roux-en-Y胃旁路手术解剖患者,评估EUS引导经肠ERCP(EDEE)新造肠肠吻合后行ERCP的可行性。LAMS置入技术成功率100%,ERCP成功率94.44%,临床成功17例(94.4%),不良事件1例(5.6%;腹痛)。提示EDEE使用LAMS在此类复杂胰胆疾病患者中可行且安全。

要点

  • EDEE使用LAMS在非RYGB手术解剖患者中技术成功率高。
  • 临床成功率94.4%,仅1例腹痛不良事件。
  • 多数患者分期行EDEE,两操作中位间隔21天。

核心结论

  • EDEE使用LAMS在非RYGB手术解剖且复杂胰胆疾病患者中可行且安全。

研究设计与样本

  • 多中心回顾性研究,7个中心,2014年1月至2018年10月,纳入18例患者(平均年龄63岁;13例女性)。

主要发现

  • 最常见手术解剖为Whipple术(10/18)和Roux-en-Y肝肠吻合术(6/18)。
  • EUS引导LAMS置入技术成功率100%,ERCP技术成功率94.44%(17/18)。
  • 14例患者分期行EDEE,两操作中位间隔21天(IQR 11.5-36)。
  • 中位总操作时间111分钟(IQR 81-192)。
  • 中位随访88天(IQR 54-142)期间,临床成功17例(94.4%),不良事件1例(5.6%;腹痛)。

临床怎么用

  • 对于非RYGB手术解剖患者,EDEE使用LAMS可作为ERCP的可行选择。

局限性

  • 回顾性设计且样本量小(18例),随访时间较短。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND AND AIMS: Enteroscopy-assisted ERCP is challenging in patients with surgically altered upper GI anatomy. This study evaluated a novel procedure, EUS-directed transenteric ERCP (EDEE), in the de novo creation of an enteroenteric anastomosis for the performance of ERCP in non-Roux-en Y gastric bypass (RYGB) patients. METHODS: This was a multicenter retrospective study involving 7 centers between January 2014 and October 2018. Primary outcome was clinical success (completion of EDEE and ERCP with intended interventions), and secondary outcomes were technical success and rate/severity of adverse events. RESULTS: Eighteen patients (mean age, 63 years; 13 women) were included. The most common type of surgical anatomy was Whipple (10/18) and Roux-en-Y hepaticojejunostomy (6/18). Technical success rate of EUS-guided lumen-apposing metal stent (LAMS) placement was 100% and of ERCP was 94.44% (17/18). Fourteen patients underwent separate-session EDEE with a median of 21 days (interquartile range [IQR], 11.5-36) between the 2 procedures. Median total procedure time was 111 minutes (IQR, 81-192). Clinical success and adverse events occurred in 17 (94.4%) and 1 (5.6%; abdominal pain) patients, respectively, during a median follow-up of 88 days (IQR, 54-142). CONCLUSIONS: This study suggests that EDEE using LAMSs is feasible and safe in patients with non-RYGB surgical anatomy and complex pancreaticobiliary pathologies.

来源:Gastrointest Endosc,查看原文。版权归原作者所有。

引用

  1. Ichkhanian Y, Yang J, James TW, et al. EUS-directed transenteric ERCP in non-Roux-en-Y gastric bypass surgical anatomy patients (with video). Gastrointest Endosc. 2020. PMID: 31917168. doi:10.1016/j.gie.2019.12.043

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。